Literature DB >> 12478538

Transcervical superior mediastinal lymphadenectomy in the management of papillary thyroid carcinoma.

Mark L C Khoo1, Jeremy L Freeman.   

Abstract

AIM: Surgery is the treatment of choice for lymph node metastases in papillary thyroid carcinoma. When adequately treated by surgical extirpation, the presence of lymph node involvement does not seem to have a negative impact on cure rates or survival. Surgical lymphadenectomy for metastatic papillary thyroid carcinoma has been well described for both the central and the lateral compartments of the neck. Superior mediastinal lymphadenectomy, however, has only sporadically been mentioned. We describe our experience with transcervical superior mediastinal lymphadenectomy (TSML) that avoids the morbidity of the traditional sternal split.
MATERIALS AND METHODS: This retrospective analysis included 30 patients (24 women and 6 men; age range, 17-72 years) who underwent TSML by the senior author (JLF) for papillary carcinoma metastatic to the superior mediastinum between 1985 and 1999. Histopathologic examination confirmed positive nodes in all the mediastinal dissections. All patients received postoperative I(131).
RESULTS: All the patients are alive after a median follow-up of 5 years (range, 1-14 years). Twenty-nine of 30 patients remain free of disease, whereas one patient is alive with lung and bone metastases. No patient has had local or regional relapse. The only significant complication was a high incidence of temporary (70%) and later permanent (50%) hypoparathyroidism.
CONCLUSIONS: TSML is a safe and effective treatment for superior mediastinal metastases in papillary thyroid carcinoma. Copyright 2002 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2003        PMID: 12478538     DOI: 10.1002/hed.10173

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  5 in total

1.  Video-assisted superior mediastinal lymphadenectomy for papillary thyroid cancer: a case report.

Authors:  J Zhao; X Zheng; M Gao; J Chi; S Wei; X Yun
Journal:  Ann R Coll Surg Engl       Date:  2022-06-17       Impact factor: 1.951

2.  Skip metastases in medullary thyroid carcinoma: a single-center experience.

Authors:  Marcos R Tavares; Pedro Michaluart; Fabio Montenegro; Sergio Arap; Maria Sodre; Flavio Takeda; Lenine Brandao; Sergio Toledo; Alberto Ferraz
Journal:  Surg Today       Date:  2008-05-31       Impact factor: 2.549

3.  Mediastinal Lymph Node Metastases in Thyroid Cancer: Characteristics, Predictive Factors, and Prognosis.

Authors:  Ting-Ting Zhang; Ning Qu; Jia-Qian Hu; Rong-Liang Shi; Duo Wen; Guo-Hua Sun; Qing-Hai Ji
Journal:  Int J Endocrinol       Date:  2017-11-12       Impact factor: 3.257

Review 4.  Imaging for staging and management of thyroid cancer.

Authors:  Ann D King
Journal:  Cancer Imaging       Date:  2008-03-25       Impact factor: 3.909

5.  Predictive Factors of Superior Mediastinal Nodal Metastasis from Papillary Thyroid Carcinoma--A Prospective Observational Study.

Authors:  Joo Hyun Woo; Ki Nam Park; Jae Yong Lee; Seung Won Lee
Journal:  PLoS One       Date:  2016-02-05       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.